Nanosized particulate systems for dermal and transdermal delivery

Journal of Biomedical Nanotechnology

Volumn 6, Issue 6, 2010, Pages 621-633

  Kamel Hassan, Amany O ^a   Elshafeey, Ahmed H ^b  

^a Ain Shams University   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Microemulsion; Nanostructured lipid carriers; Solid lipid nanoparticles; Transdermal; Vesicular systems

Indexed keywords

NANO-SIZED; NANO-SIZED PARTICLES; NANO-SIZED PARTICULATES; NANOAPRTICLES; NANOSTRUCTURED LIPID CARRIERS; PHARMACEUTICAL FORMULATION; POLYMERIC NANOPARTICLES; SKIN DELIVERY; SOLID LIPID NANOPARTICLES; TRANSDERMAL; TRANSDERMAL DELIVERY; VESICULAR SYSTEMS;

DRUG PRODUCTS; NANOPARTICLES;

MICROEMULSIONS;

ALCOHOL; CHOLESTEROL; CINEOLE; DICLOFENAC; DIETHYLENE GLYCOL MONOETHYL ETHER; EMLA; ESTRADIOL; FLURBIPROFEN; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; HYDROCORTISONE; KETOROLAC; LABRASOL; LIPOSOME; MELATONIN; METHOTREXATE; MICONAZOLE; MINOXIDIL; NANO LIDO GEL; NANOPARTICLE; NIOSOME; PENETRATION ENHANCING AGENT; PHOSPHATIDYLCHOLINE; PREDNICARBATE; PROPYLENE GLYCOL; SOLID LIPID NANOPARTICLE; SORBITAN PALMITATE; SORBITAN STEARATE; SULFADIAZINE; TEMOPORFIN; TERPENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; DRUG;

BILAYER MEMBRANE; CREAM; DRUG ABSORPTION; DRUG PENETRATION; HUMAN; MICROEMULSION; NANOTECHNOLOGY; NONHUMAN; OINTMENT; PARTICLE SIZE; REVIEW; DRUG DELIVERY SYSTEM; INTRADERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS;

EID: 79953021814     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2010.1141     Document Type: Review

References (165)

1. A. C. Sintov, I. Krymberk, D. Daniel, T. Hannan, Z. Sohn, and G. Levin, Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J. Controlled Release 89, 311 (2003).
2. S. N. Murthy, Magnetophoresis: An approach to enhance transdermal drug diffusion. Pharmazie 54, 377 (1999).
3. F. Akomeah, T. Nazir, G. P. Martin, and M. B. Brown, Effect of heat on the percutaneous absorption and skin retention of three model penetrants. Eur. J. Pharm. Sci. 21, 337 (2004).
4. S. V. Vinagradov, T. K. Bronich, and A. V. Kabanov, Nanosized cationic hydrogels for drug delivery: Preparation, properties and interactions with cells. Adv. Drug Del. Rev. 54, 223 (2002).
5. www.radcliffe-oxford.com/books/.../01-bensouillah-241a6c80rdz.pdf.
6. www.nku.edu/~dempseyd/SKIN.htm
7. G. Cevc, Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev. 56, 675 (2004).
8. P. W. Wertz, and D. T. Downing, Epidermal lipids. In Physiology, Biochemistry, and Molecular Biology of the Skin, edited L. A. Goldsmith, Oxford University Press, New York (1991), pp. 1205-236.
9. G. Cevc, A. G. Schatzlein, H. Richardson, and U. Vieri, Overcoming semipermeable barriers, such as the skin, with ultrade-formable mixed lipid vesicles, transfersomes, liposomes, or mixed lipid micelles. Langmuir 19, 10753 (2003).
10. L. B. Lawson, L. C. Freytag, and J. D. Clements, Use of nanocarriers for transdermal vaccine delivery. Clin. Pharm. and Therap. 82, 6 (2007).
11. K. Kriwet and C. C. Muller-Goymann, Diclofenac release from phospholipid drug systems and permeation through excised human stratum corneum. Int. J. Pharm. 125, 231 (1995).
12. F. P. Bonina, L. Montenegro, N. Scrofani, E. Esposito, R. Cortesi, E. Menegatti, and C. Nastruzzi, Effects of phospholipids based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate. J. Controlled Release 34, 53 (1995).
13. M. B. Delgado-Charro, G. Iglesias-Vilas, J. Blanco-Mendez, M. A. Lopez-Quintela, and R. H. Guy, Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur. J. Pharm. Biopharm. 43, 37 (1997).
14. F. Dreher, P. Walde, P. Walther, and E. Wehrli, Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J. Controlled Release 45, 131 (1997).
15. L. Boltri, S. Morel, M. Trotta, and M. R. Gasco, In vitro transdermal permeation of nifedipine from thickened microemulsions. J. Pharm. Belg. 49, 315 (1994).
16. M. Trotta, S. Morel, and M. R. Gasco, Effect of oil phase composition on the skin permeation of felodipine from o/w microemulsions. Pharmazie 52, 50 (1997).
17. M. Trotta, M. R. Gasco, O. Caputo, and P. Sancin, Transcutaneous diffusion of hematoporphyrin in photodynamic therapy: In vitro release from microemulsions. STP Pharma. Sci. 4, 150 (1994).
18. M. Kreilgaard, E. J. Pedersen, and J. W. Jaroszewski, NMR characterisation and transdermal drug delivery potential of microemulsion systems. J. Controlled Release 69, 421 (2000).
19. D. Atwood, Microemulsions. Colloidal drug delivery system, edited H. Kreuter, Marcel and Dekker, New York, (1994).
20. M. E. Gilliam, Microemulsions. Encyclopedia of Pharmaceutical Technology, (1998), 9, pp. 375-421.
21. M. A Bolzinger, S. Briancon, J. Pelletier, H. Fessi, and Y. Chevalier, Percutaneous release of caffeine from microemulsion, emulsion and gel dosage forms. Eur. J. Pharm. Biopharm. 68, 446 (2008).
22. G. Ktistis and I. Niopas, A study on the in-vitro percutaneous absorption of propranolol from disperse systems. J. Pharm. Pharmacol. 50, 413 (1998).
23. M. R. Gasco, M. Gallarate, and F. Pattarino, In vitro permeation of azelaic acid from viscosized microemulsions. Int. J. Pharm. 69, 193 (1991).
24. Z. Abramovic, U. Sustarsic, K. Teskac, M. Sentjurc, and J. Kristl, Influence of nanosized delivery systems with benzyl nicotinate and penetration enhancers on skin oxygenation. Int. J. Pharm. 359, 220 (2008).
25. M. Trotta, Influence of phase transformation on indomethacin release from microemulsions. J. Controlled Release 60, 399 (1999).
26. W. Zhu, A. Yu, W. Wang, R. Dong, J. Wu, and G. Zhai, Formulation design of microemulsion for dermal delivery of penciclovir. Int. J. Pharm. 360, 184 (2008).
27. A. Teichmann, S. Heuschkel, U. Jacobi, G. Presse, R. H. H. Neubert, and W. Sterry, Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur. J. Pharm. Biopharm. 67, 699 (2007).
28. A. Fini, V. Bergamante, G. C. Ceschel, C. Ronchi, and C. A. De Moraes, Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations. AAPS Pharm. Sci. Tech. 9, 762 (2008).
29. M. A. Bolzinger, T. C. Carduner, and M. C. Poelman, Bicontinuous sucrose ester microemulsion: A new vehicle for topical delivery of niflumic acid. Int. J. Pharm. 176, 39 (1998).
30. M. Kreilgaard, Influence of microemulsions on cutaneous drug delivery. Adv. Drug Del. Rev. 54 Suppl. 1, S77-S98 (2002).
31. C. Malcolmson and M. J. Lawrence, A comparison between non-ionic micelles and microemulsions as a means of incorporating the poorly water soluble drug diazepam. J. Pharm. Pharmacol. Suppl. 42, 6P (1990).
32. C. Malcolmson, C. Satra, S. Kantaria, A. Sidhu, and M. J. Lawrence, Effect of oil on the level of solubilization of testosterone propionate into nonionic oil-in-water microemulsions. J. Pharm. Sci. 87, 109 (1998).
33. C. Malcolmson and M. J. Lawrence, Comparison of the incorporation of model steroids into non-ionic micellar and microemulsion systems. J. Pharm. Pharmacol. 45, 141 (1993).
34. A. Azeem, F. J. Ahmad, R. K. Khar, and S. Talegaonkar, Nanocarrier for the transdermal delivery of an antiparkinsonian drug. AAPS PharmSciTech DOI: 10.1208/s12249-009-9306-2 (2009).
35. S. Kitagawa, Y. Tanaka, M. Tanaka, K. Endo, and A. Yoshii, Enhanced skin delivery of quercetin by microemulsion. J. Pharm. Pharmacol. 61, 855 (2009).
36. S. Pappinen and A. Urtti, Microemulsions in topical drug delivery. In: Smith EW, Maibach HI, eds. Percutaneous Penetration Enhancers, 2nd edn. Boca Raton: CRC, 109-116 (2006).
37. M. B. Delgado-Charro, G. Iglesias-Vilas, J. Blanco-Méndez, M. A. López-Quintela, J. Marty, and R. H. Guy, Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur. J. Pharm. Biopharm. 43, 37 (1997).
38. Shishu, S. Rajan, and Kamalpreet, Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections. AAPS Pharm. Sci. Tech. 10, 559 (2009).
39. A. Ganem-Quintanar, C. Lafforgue, F. Falson-Rieg, and P. Buri, Evaluation of the transepidermal permeation of diethyleneglycol monoethylether and skin water loss. Int. J. Pharm. 147, 165 (1997).
40. A. Godwin, N. H. Kim, and L. A. Felton, Influence of Transcutol CG on the skin accumulation and transepidermal permeation of ultraviolet absorbers. Eur. J. Pharm. Biopharm. 53, 23 (2002).
41. W. Zhu, C. Guo, A. Yu, Y. Gao, F. Cao, and G. Zhai, Microemulsion-based hydrogel formulation of penciclovir for topical delivery. Int. J. Pharm. 13, 152 (2009).
42. Y. B. Huang, Y. H. Lin, T. M. Lu, R. J. Wang, Y. H. Tsai, and P. C. Wu, Transdermal delivery of capsaicin derivative-sodium nonivamide acetate using microemulsions as vehicles. Int. J. Pharm. 349, 206 (2008).
43. G. M. El Maghraby, Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: Effects of cosurfactants. Int. J. Pharm. 355, 285 (2008).
44. D. Kumar, M. Aqil, M. Rizwan, Y. Sultana, and M. Ali, Investigation of a nanoemulsion as vehicle for transdermal delivery of amlodipine. Pharmazie 64, 80 (2009).
45. Y. Yuan, S. Li, F. Mo, and D. Zhong, Investigation of microemulsion system for transdermal delivery of meloxicam. Int. J. Pharm. 321, 117 (2006).
46. H. Chen, X. Chang, T. Weng, X. Zhao, Z. Gao, Y. Yang, H. Xu, and X. Yang, A study of microemulsion systems for transdermal delivery of triptolide. J. Controlled Release 98, 427 (2004).
47. Y. S. Rhee, J. G. Choi, E. S. Park, and S. C. Chi, Transdermal delivery of ketoprofen using microemulsions. Int. J. Pharm. 228, 161 (2001).
48. X. Zhao, J. P. Liu, X. Zhang, and Y. Li, Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int. J. Pharm. 327, 58 (2006).
49. A. H. Elshafeey, A. O. Kamel, and M. M. Fathallah, Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: Ex-vivo permeation and in-vivo pharmacokinetic studies. Pharm. Res. 26, 11 (2009).
50. M. J. Alvarez-Figueroa and J. Blanco-Mendez, Transdermal delivery of methotrexate: Iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int. J. Pharm. 215, 57 (2001).
51. J. H. Kweon, S. C. Chi, and E. S. Park, Transdermal delivery of diclofenac using microemulsions. Arch. Pharm. Res. 27, 351 (2004).
52. M. Mezei and V. Gulasekharam, Liposomes: A selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci. 26, 1473 (1980).
53. N. F. H. Ho, M. G. Ganesan, and G. L. Flynn, Mechanisms of topical delivery of liposomally entrapped drugs. J. Controlled Release 2, 61 (1985).
54. J. Lash, R. Laub, and W. Wohlrab, How deep do intact liposomes penetrate into human skin? J. Controlled Release 18, 55 (1991).
55. B. A. I. van den Bergh, I. Salomons-de Vries, and J. A. Bouwstra, Interactions between liposomes and human stratum corneum studied by freeze-substitution electron microscopy. Int. J. Pharm. 167, 57 (1998).
56. G. Cevc and G. Blume, Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 17, 226 (1992).
57. G. M. El Maghraby, A. C. Williams, and B. W. Barry, Skin delivery of oestradiol from deformable and traditional liposomes: Mechanistic studies. J. Pharm. Pharmacol. 51, 1123 (1999).
58. M. E. Planas, P. Gonzalez, L. Rodriguez, S. Sanchez, and G. Cevc, Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth. Analg. 75, 615 (1992).
59. G. Cevc, Dermal insulin. Frontiers in insulin pharmacology, edited M. Berger, A. Gries, Stutgart: Georg Thieme; (1993), pp. 61-74.
60. G. Cevc, D. Gebauer, J. Stieber, A. Schätzlein, and G. Blume, Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1368, 201 (1998).
61. G. Cevc, Transfersomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Then Drug Carrier Syst. 13, 257 (1996).
62. B. A. I. van den Bergh, J. Vroom, H. Gerritsen, H. E. Junginger, and A. Joke, Interactions of elastic and rigid vesicles with human skin in vitro: Electron microscopy and two-photon excitation microscopy. Bouwstra Biochimica et Biophysica Acta (BBA) - Biomembranes 1461, 155 (1999).
63. L. Tavano, R. Muzzalupo, R. Cassano, S. Trombino, T. Ferrarelli, and N. Picci, New sucrose cocoate based vesicles: Preparation characterization and skin permeation studies. Colloids Surf. B Biointerfaces 75, 319 (2010).
64. A. Rogerson, J. Cummings, and A. T. Florence, J. Microencapsul. 4, 321 (1987).
65. B. Nasseri, Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int. J. Pharm. 300, 95 (2005).
66. B. Vora, A. J. Khopade, and N. K. Jain, Proniosome based transdermal delivery of levonorgestrel for effective contraception. J. Controlled Release 54, 149 (1998).
67. B. Y. Huang, B. H. Jung, S. J. Chung, M. H. Lee, and C. K. Shim, In vitro skin permeation of nicotine from proliposomes. J. Controlled Release 49, 177 (1997).
68. J. Varshosaz, A. Pardakhty, and M. H. B. Seied, Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Deliv. 12, 75 (2005).
69. J. Y. Fang, S. Y. Yu, P. C. Wu, Y. B. Huang, and Y. H. Tsai, In vitro skin permeation of estradiol from various proniosome formulations. Int. J. Pharm. 215, 91 (2001).
70. I. A. Alsarra, A. A. Bosela, S. M. Ahmed, and G. M. Mahrous, Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm. 59, 485 (2005).
71. M. M. Ibrahim, O. A. Sammour, M. A. Hammad, and N. A. Megrab, In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS Pharm. Sci. Tech. 9, 782 (2008).
72. V. Sankar, C. Praveen, K. G. Prasanth, C. R. Srinivas, and K. Ruckmann, Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream. Pharmazie 64, 731 (2009).
73. E. Touitou, N. Dayan, L. Bergelson, B. Godin, and M. Eliaz, Ethosomes-novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J. Controlled Release 65, 403 (2000).
74. S. Jain, A. K. Tiwary, B. Sapra, and N. K. Jain, Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS Pharm. Sci. Tech. 8, E111 (2007).
75. V. Dubey, D. Mishra, T. Dutta, M. Nahar, D. K. Saraf, and N. K. Jain, Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J. Controlled Release 123, 148 (2007).
76. V. Dubey, D. Mishra, and N. K. Jain, Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery. Eur. J. Pharm. Biopharm. 67, 398 (2007).
77. N. Dragicevic-Curic, D. Scheglmann, V. Albrecht, and A. Fahr, Development of liposomes containing ethanol for skin delivery of temoporfin: Characterization and in vitro penetration studies. Colloids Surf. B Biointerfaces 74, 114 (2009).
78. M. M. A. Elsayed, O. Y. Abdallah, V. F. Naggar, and N. M. Khalafallah, PG-liposomes: Novel lipid vesicles for skin delivery of drugs. J. Pharm. Pharmacol. 59, 1447 (2007).
79. G. M. M. El Maghraby, A. C. Williams, and B. W. Barry, Skin delivery of oestradiol from lipid vesicles: Importance of liposome structure. Int. J. Pharm. 204, 159 (2000).
80. N. Dragicevic-Curic, D. Scheglmann, V. Albrecht, and A. Fahr, Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies. J. Controlled Release 127, 59 (2008).
81. S. Mura, M. Manconia, C. Sinicoa, D. Valentia, and A. M. Faddaa, Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int. J. Pharm. 380, 72 (2009).
82. R. H. Müller, M. Radtke, and S. A. Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54, S131 (2002).
83. R. H. Müller, M. Radtke, and S. A. Wissing, Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 242, 121 (2002).
84. J. S. Lucks and R. H. Müller, Medication vedicles made of solid lipid particles (solid lipid Nanospheres SLN). EP0000605497 (1991).
85. V. Jenning, M. Schäfer-Korting, and S. Gohla, Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. J. Controlled Release 66, 115 (2000).
86. V. Jenning and S. H. Gohla, Encapsulation of retinoids in solid lipid nanoparticles (SLN). J. Microencapsul 18, 149 (2001).
87. S. Küchler, M. R. Radowski, T. Blaschke, M. Dathe, J. Plendl, R. Haag, M. Schäfer-Korting, and K. D. Kramer, Nanoparticles for skin penetration enhancement-a comparison of a dendritic core-multishell- nanotransporter and solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 71, 243 (2009).
88. J. Kuntsche, H. Bunjes, A. Fahr, S. Pappinen, S. Ronkko, M. Suhonen, and A. Urtti, Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model. Int. J. Pharm. 354, 180 (2008).
89. C. Santos Maia, W. Mehnert, M. Schaller, H. C. Korting, A. Gysier, A. Haberland, and M. Schäfer-Korting, Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target 10, 489 (2002).
90. M. R. Bhalekar, V. Pokharkar, A. Madgulkar, and N. Paul, Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS Pharm. Sci. Tech. 10, 289 (2009).
91. S. D. Mandawgade and V. B. Patravale, Development of SLNs from natural lipids: Application to topical delivery of tretinoin. Int. J. Pharm. 363, 132 (2008).
92. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu, and X. Yang, Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 10, 191 (2007).
93. S. Küchler, M. Abdel-Mottaleb, A. Lamprechtb, M. R. Radowski, R. Haag, and M. Schäfer-Korting, Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int. J Pharm. 377, 169 (2009).
94. V. Sanna, E. Gavini, M. Cossu, G. Rassu, and P. Giunchedi, Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: In-vitro characterization, ex-vivo and in-vivo studies. J. Pharm. Pharmacol. 59, 1057 (2007).
95. K. Teskac and J. Kristl, The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 5, 61 (2010).
96. Y. K. Lin, Z. R. Huang, R. Z. Zhuo, and J. Y. Fang, Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int. J. Nanomedicine 9, 117 (2010).
97. K. Bhaskar, J. Anbul, V. Ravichandiran, V. Venkateswarlu, and Y. M. Rao, Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies. Lipids in Health and Disease 8, 1 (2009).
98. J. J. Wang, K. S. Liu, K. C. Sung, C. Y. Tsai, and J. Y. Fang, Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: Lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles. J. Microencapsul. 26, 734 (2009).
99. R. Alvarez-Román, A. Naik, Y. N. Kalia, R. H. Guý, and H. Fessi, Skin penetration and distribution of polymeric nanoparticles. J. Controlled Release 99, 53 (2004).
100. J. Luengo, B. Weiss, M. Schneider, A. Ehlers, F. Stracke, K. König, K. H. Kostka, C. M. Lehr, and U. F. Schaefer, Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol. Physiol. 19, 190 (2006).
101. M. Gou, L. Wu, Q. Yin, Q. Guo, G. Guo, J. Liu, X. Zhao, Y. Wei, and Z. Qian, Transdermal anaesthesia with lidocaine nano-formulation pretreated with low-frequency ultrasound in rats model. J. Nanosci. Nanotechnol. 9, 6360 (2009).
102. L. Sheihet, P. Chandra, P. Batheja, D. Devore, J. Kohn, and B. Michniak, Tyrosine-derived nanospheres for enhanced topical skin penetration. Int. J. Pharm. 350, 312 (2008).
103. J. Panyam and V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329 (2003).
104. S. Prabha, W-Z. Zhou, J. Panyam, and V. Labgasetwar, Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int. J. Pharm. 244, 105 (2002).
105. J. Shim, H. S. Kang, W Park, S. Han, J. Kim, and I. Chang, Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J. Controlled Release 97, 477 (2004).
106. P. Lee, S. Peng, C. Su, F. Mi, H. Chen, M. Wei, H. Lin, and H. Sung, The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials 29, 742 (2008).
107. X. Zhao, J. P. Liu, X. Zhang, and Y. Li, Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int. J. Pharm. 327, 58 (2006).
108. A. H. Elshafeey, A. O. Kamel, and M. M. Fathallah, Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: Ex-vivo permeation and in-vivo pharmacokinetic studies. Pharm. Res. 26, 11 (2009).
109. M. J. Alvarez-Figueroa and J. Blanco-Mendez, Transdermal delivery of methotrexate: Iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int. J. Pharm. 215, 57 (2001).
110. J. H. Kweon, S. C. Chi, and E. S. Park, Transdermal delivery of diclofenac using microemulsions. Arch. Pharm. Res. 27, 351 (2004).
111. M. Mezei and V. Gulasekharam, Liposomes: A selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci. 26, 1473 (1980).
112. N. F. H. Ho, M. G. Ganesan, and G. L. Flynn, Mechanisms of topical delivery of liposomally entrapped drugs. J. Controlled Release 2, 61 (1985).
113. J. Lash, R. Laub, and W. Wohlrab, How deep do intact liposomes penetrate into human skin? J. Controlled Release 18, 55 (1991).
114. B. A. I. van den Bergh, I. Salomons-de Vries, and J. A. Bouwstra, Interactions between liposomes and human stratum corneum studied by freeze-substitution electron microscopy. Int. J. Pharm. 167, 57 (1998).
115. G. Cevc and G. Blume, Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 17, 226 (1992).
116. G. M. El Maghraby, A. C. Williams, and B. W. Barry, Skin delivery of oestradiol from deformable and traditional liposomes: Mechanistic studies. J. Pharm. Pharmacol. 51, 1123 (1999).
117. M. E. Planas, P. Gonzalez, L. Rodriguez, S. Sanchez, and G. Cevc, Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth. Analg. 75, 615 (1992).
118. G. Cevc, Dermal insulin. Frontiers in insulin pharmacology, edited M. Berger, A. Gries, Stutgart: Georg Thieme; (1993), pp. 61-74.
119. G. Cevc, D. Gebauer, J. Stieber, A. Schätzlein, and G. Blume, Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1368, 201 (1998).
120. G. Cevc, Transfersomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Then Drug Carrier Syst. 13, 257 (1996).
121. B. A. I. van den Bergh, J. Vroom, H. Gerritsen, H. E. Junginger, and A. Joke, Interactions of elastic and rigid vesicles with human skin in vitro: Electron microscopy and two-photon excitation microscopy. Bouwstra Biochimica et Biophysica Acta (BBA) - Biomembranes 1461, 155 (1999).
122. L. Tavano, R. Muzzalupo, R. Cassano, S. Trombino, T. Ferrarelli, and N. Picci, New sucrose cocoate based vesicles: Preparation characterization and skin permeation studies. Colloids Surf. B Biointerfaces 75, 319 (2010).
123. A. Rogerson, J. Cummings, and A. T. Florence, J. Microencapsul. 4, 321 (1987).
124. B. Nasseri, Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int. J. Pharm. 300, 95 (2005).
125. B. Vora, A. J. Khopade, and N. K. Jain, Proniosome based transdermal delivery of levonorgestrel for effective contraception. J. Controlled Release 54, 149 (1998).
126. B. Y. Huang, B. H. Jung, S. J. Chung, M. H. Lee, and C. K. Shim, In vitro skin permeation of nicotine from proliposomes. J. Controlled Release 49, 177 (1997).
127. J. Varshosaz, A. Pardakhty, and M. H. B. Seied, Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Deliv. 12, 75 (2005).
128. J. Y. Fang, S. Y. Yu, P. C. Wu, Y. B. Huang, and Y. H. Tsai, In vitro skin permeation of estradiol from various proniosome formulations. Int. J. Pharm. 215, 91 (2001).
129. I. A. Alsarra, A. A. Bosela, S. M. Ahmed, and G. M. Mahrous, Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm. 59, 485 (2005).
130. M. M. Ibrahim, O. A. Sammour, M. A. Hammad, and N. A. Megrab, In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS Pharm. Sci. Tech. 9, 782 (2008).
131. V. Sankar, C. Praveen, K. G. Prasanth, C. R. Srinivas, and K. Ruckmann, Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream. Pharmazie 64, 731 (2009).
132. E. Touitou, N. Dayan, L. Bergelson, B. Godin, and M. Eliaz, Ethosomes-novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J. Controlled Release 65, 403 (2000).
133. S. Jain, A. K. Tiwary, B. Sapra, and N. K. Jain, Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS Pharm. Sci. Tech. 8, E111 (2007).
134. V. Dubey, D. Mishra, T. Dutta, M. Nahar, D. K. Saraf, and N. K. Jain, Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J. Controlled Release 123, 148 (2007).
135. V. Dubey, D. Mishra, and N. K. Jain, Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery. Eur. J. Pharm. Biopharm. 67, 398 (2007).
136. N. Dragicevic-Curic, D. Scheglmann, V. Albrecht, and A. Fahr, Development of liposomes containing ethanol for skin delivery of temoporfin: Characterization and in vitro penetration studies. Colloids Surf. B Biointerfaces 74, 114 (2009).
137. M. M. A. Elsayed, O. Y. Abdallah, V. F. Naggar, and N. M. Khalafallah, PG-liposomes: Novel lipid vesicles for skin delivery of drugs. J. Pharm. Pharmacol. 59, 1447 (2007).
138. G. M. M. El Maghraby, A. C. Williams, and B. W. Barry, Skin delivery of oestradiol from lipid vesicles: Importance of liposome structure. Int. J. Pharm. 204, 159 (2000).
139. N. Dragicevic-Curic, D. Scheglmann, V. Albrecht, and A. Fahr, Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies. J. Controlled Release 127, 59 (2008).
140. S. Mura, M. Manconia, C. Sinicoa, D. Valentia, and A. M. Faddaa, Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int. J. Pharm. 380, 72 (2009).
141. R. H. Müller, M. Radtke, and S. A. Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54, S131 (2002).
142. R. H. Müller, M. Radtke, and S. A. Wissing, Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 242, 121 (2002).
143. J. S. Lucks and R. H. Müller, Medication vedicles made of solid lipid particles (solid lipid Nanospheres SLN). EP0000605497 (1991).
144. V. Jenning, M. Schäfer-Korting, and S. Gohla, Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. J. Controlled Release 66, 115 (2000).
145. V. Jenning and S. H. Gohla, Encapsulation of retinoids in solid lipid nanoparticles (SLN). J. Microencapsul 18, 149 (2001).
146. S. Küchler, M. R. Radowski, T. Blaschke, M. Dathe, J. Plendl, R. Haag, M. Schäfer-Korting, and K. D. Kramer, Nanoparticles for skin penetration enhancement-a comparison of a dendritic core-multishell- nanotransporter and solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 71, 243 (2009).
147. J. Kuntsche, H. Bunjes, A. Fahr, S. Pappinen, S. Ronkko, M. Suhonen, and A. Urtti, Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model. Int. J. Pharm. 354, 180 (2008).
148. C. Santos Maia, W. Mehnert, M. Schaller, H. C. Korting, A. Gysier, A. Haberland, and M. Schäfer-Korting, Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target 10, 489 (2002).
149. M. R. Bhalekar, V. Pokharkar, A. Madgulkar, and N. Paul, Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS Pharm. Sci. Tech. 10, 289 (2009).
150. S. D. Mandawgade and V. B. Patravale, Development of SLNs from natural lipids: Application to topical delivery of tretinoin. Int. J. Pharm. 363, 132 (2008).
151. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu, and X. Yang, Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 10, 191 (2007).
152. S. Küchler, M. Abdel-Mottaleb, A. Lamprechtb, M. R. Radowski, R. Haag, and M. Schäfer-Korting, Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int. J Pharm. 377, 169 (2009).
153. V. Sanna, E. Gavini, M. Cossu, G. Rassu, and P. Giunchedi, Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: In-vitro characterization, ex-vivo and in-vivo studies. J. Pharm. Pharmacol. 59, 1057 (2007).
154. K. Teskac and J. Kristl, The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 5, 61 (2010).
155. Y. K. Lin, Z. R. Huang, R. Z. Zhuo, and J. Y. Fang, Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int. J. Nanomedicine 9, 117 (2010).
156. K. Bhaskar, J. Anbul, V. Ravichandiran, V. Venkateswarlu, and Y. M. Rao, Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies. Lipids in Health and Disease 8, 1 (2009).
157. J. J. Wang, K. S. Liu, K. C. Sung, C. Y. Tsai, and J. Y. Fang, Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: Lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles. J. Microencapsul. 26, 734 (2009).
158. R. Alvarez-Román, A. Naik, Y. N. Kalia, R. H. Guý, and H. Fessi, Skin penetration and distribution of polymeric nanoparticles. J. Controlled Release 99, 53 (2004).
159. J. Luengo, B. Weiss, M. Schneider, A. Ehlers, F. Stracke, K. König, K. H. Kostka, C. M. Lehr, and U. F. Schaefer, Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol. Physiol. 19, 190 (2006).
160. M. Gou, L. Wu, Q. Yin, Q. Guo, G. Guo, J. Liu, X. Zhao, Y. Wei, and Z. Qian, Transdermal anaesthesia with lidocaine nano-formulation pretreated with low-frequency ultrasound in rats model. J. Nanosci. Nanotechnol. 9, 6360 (2009).
161. L. Sheihet, P. Chandra, P. Batheja, D. Devore, J. Kohn, and B. Michniak, Tyrosine-derived nanospheres for enhanced topical skin penetration. Int. J. Pharm. 350, 312 (2008).
162. J. Panyam and V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329 (2003).
163. S. Prabha, W-Z. Zhou, J. Panyam, and V. Labgasetwar, Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int. J. Pharm. 244, 105 (2002).
164. J. Shim, H. S. Kang, W Park, S. Han, J. Kim, and I. Chang, Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J. Controlled Release 97, 477 (2004).
165. P. Lee, S. Peng, C. Su, F. Mi, H. Chen, M. Wei, H. Lin, and H. Sung, The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials 29, 742 (2008).